Editas Medicine (EDIT) EPS (Diluted) (QoQ) (2019 - 2025)
Editas Medicine (EDIT) EPS (Diluted) (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Editas Medicine | 245.95 Mn | 99.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 45.42% |
| Jun 30, 2025 | 35.16% |
| Mar 31, 2025 | -34.41% |
| Dec 31, 2024 | 6.23% |
| Sep 30, 2024 | 8.29% |
| Jun 30, 2024 | -2.28% |
| Mar 31, 2024 | -198.70% |
| Dec 31, 2023 | 83.47% |
| Sep 30, 2023 | 77.08% |
| Jun 30, 2023 | -72.24% |
| Mar 31, 2023 | -388.87% |
| Dec 31, 2022 | 96.36% |
| Sep 30, 2022 | -43.09% |
| Jun 30, 2022 | 72.35% |
| Mar 31, 2022 | -11,628.30% |
| Dec 31, 2021 | 49.61% |
| Sep 30, 2021 | 48.60% |
| Jun 30, 2021 | -26.92% |
| Mar 31, 2021 | -42.24% |
| Dec 31, 2020 | -955.07% |